Yesilipek MA - Search Results

1

Posttransplant oral iron-chelating therapy in patients with beta-thalassemia major.

Yesilipek MA, Karasu G, Kazik M, Uygun V, Ozturk Z. Yesilipek MA, et al. Pediatr Hematol Oncol. 2010 Aug;27(5):374-9. doi: 10.3109/08880011003739463. Pediatr Hematol Oncol. 2010. PMID: 20604682 Clinical Trial.

2

Growth and sexual maturation in children with thalassemia major.

Yesilipek MA, Bircan I, Oygür N, Ertug H, Yegin O, Güven AG. Yesilipek MA, et al. Haematologica. 1993 Jan-Feb;78(1):30-3. Haematologica. 1993. PMID: 8491419

3

L-Carnitine treatment in beta thalassemia major.

Yeşilipek MA, Hazar V, Yegin O. Yeşilipek MA, et al. Acta Haematol. 1998 Dec;100(3):162-3. doi: 10.1159/000040895. Acta Haematol. 1998. PMID: 9858797 No abstract available.

4

Peripheral blood stem cell transplantation in children with beta-thalassemia.

Yesilipek MA, Hazar V, Küpesiz A, Kizilörs A, Uguz A, Yegin O. Yesilipek MA, et al. Bone Marrow Transplant. 2001 Dec;28(11):1037-40. doi: 10.1038/sj.bmt.1703284. Bone Marrow Transplant. 2001. PMID: 11781613

5

Unrelated cord blood transplantation in children with severe congenital neutropenia.

Yesilipek MA, Tezcan G, Germeshausen M, Kupesiz A, Uygun V, Hazar V. Yesilipek MA, et al. Pediatr Transplant. 2009 Sep;13(6):777-81. doi: 10.1111/j.1399-3046.2008.01048.x. Epub 2008 Sep 26. Pediatr Transplant. 2009. PMID: 18992063

6

Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.

Yesilipek MA, Karasu GT, Kupesiz A, Uygun V, Hazar V. Yesilipek MA, et al. J Pediatr Hematol Oncol. 2009 Jul;31(7):512-5. doi: 10.1097/MPH.0b013e3181a1c27a. J Pediatr Hematol Oncol. 2009. PMID: 19564748 Clinical Trial.

7

Successful hematopoietic SCT from non-identical twins to two sisters with β-thalassemia major by using preimplantation genetic diagnosis and HLA typing.

Yesilipek MA, Karasu G, Erçelen N, Uygun V, Akcan M, Kupesiz A, Hazar V. Yesilipek MA, et al. Bone Marrow Transplant. 2011 Dec;46(12):1581-2. doi: 10.1038/bmt.2010.344. Epub 2011 Jan 17. Bone Marrow Transplant. 2011. PMID: 21243023 No abstract available.

8

The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation.

Karasu GT, Yesilipek MA, Karauzum SB, Uygun V, Manguoglu E, Kupesiz A, Hazar V. Karasu GT, et al. Among authors: yesilipek ma. Pediatr Blood Cancer. 2012 Mar;58(3):453-8. doi: 10.1002/pbc.23350. Epub 2011 Oct 11. Pediatr Blood Cancer. 2012. PMID: 21990066

9

HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.

Yesilipek MA, Ertem M, Cetin M, Öniz H, Kansoy S, Tanyeli A, Anak S, Kurekci E, Hazar V. Yesilipek MA, et al. Pediatr Transplant. 2012 Dec;16(8):846-51. doi: 10.1111/j.1399-3046.2012.01778.x. Epub 2012 Aug 29. Pediatr Transplant. 2012. PMID: 22931438

10

Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation.

Aldemir-Kocabaş B, Tezcan-Karasu G, Bircan I, Bircan O, Aktaş-Samur A, Yeşilipek MA. Aldemir-Kocabaş B, et al. Among authors: yesilipek ma. Pediatr Hematol Oncol. 2014 Oct;31(7):616-23. doi: 10.3109/08880018.2014.906005. Epub 2014 May 22. Pediatr Hematol Oncol. 2014. PMID: 24852067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters